000129833 001__ 129833
000129833 005__ 20241125101148.0
000129833 0247_ $$2doi$$a10.3390/biomedicines11123122
000129833 0248_ $$2sideral$$a136123
000129833 037__ $$aART-2023-136123
000129833 041__ $$aeng
000129833 100__ $$0(orcid)0000-0002-9930-3903$$aLucha-López, María Orosia$$uUniversidad de Zaragoza
000129833 245__ $$aDiacutaneous fibrolysis: an update on research into musculoskeletal and neural clinical entities
000129833 260__ $$c2023
000129833 5060_ $$aAccess copy available to the general public$$fUnrestricted
000129833 5203_ $$aDiacutaneous Fibrolysis (DF) is an instrumentally assisted manual therapy technique defined as “a specific instrumental intervention for normalizing the musculoskeletal system function after a precise diagnosis and preserving the skin’s integrity”. The aim of this technique is soft tissue mobilization with the assistance of specially designed, hook-shaped steel instruments in different musculoskeletal structures, such as the myofascia, aponeurosis, tendons, ligaments and scar tissues. Due to discrepant results between previous reviews and the quite abundant new evidence provided by recently published randomized clinical trials, we propound this narrative review to provide an update on the scientific evidence related to the fundamentals and clinical efficacy of DF. Current evidence primarily supports the mechanical effect of DF on connective soft tissues. Diminished deep tendon reflex and rigidity have been registered after the implementation of DF in healthy subjects. Though there is still much to uncover, scientific evidence supports the use of the technique for the clinical treatment of subacromial impingement syndrome, chronic lateral epicondylalgia, chronic patellofemoral pain syndrome, mild to moderate carpal tunnel syndrome, hamstring shortening, temporomandibular disorders, tension-type headache and chronic low back pain. Additional data are essential for better recommendations in the clinical practice of DF.
000129833 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000129833 590__ $$a3.9$$b2023
000129833 592__ $$a0.962$$b2023
000129833 591__ $$aPHARMACOLOGY & PHARMACY$$b85 / 354 = 0.24$$c2023$$dQ1$$eT1
000129833 593__ $$aMedicine (miscellaneous)$$c2023$$dQ1
000129833 591__ $$aBIOCHEMISTRY & MOLECULAR BIOLOGY$$b106 / 313 = 0.339$$c2023$$dQ2$$eT2
000129833 593__ $$aBiochemistry, Genetics and Molecular Biology (miscellaneous)$$c2023$$dQ1
000129833 591__ $$aMEDICINE, RESEARCH & EXPERIMENTAL$$b65 / 189 = 0.344$$c2023$$dQ2$$eT2
000129833 594__ $$a5.2$$b2023
000129833 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000129833 700__ $$0(orcid)0000-0001-7667-2178$$aHidalgo-García, César$$uUniversidad de Zaragoza
000129833 700__ $$aMonti-Ballano, Sofía$$uUniversidad de Zaragoza
000129833 700__ $$aMárquez-Gonzalvo, Sergio$$uUniversidad de Zaragoza
000129833 700__ $$aKrauss, John
000129833 700__ $$aTricás-Vidal, Héctor José
000129833 700__ $$0(orcid)0000-0002-3583-5206$$aTricás-Moreno, José Miguel$$uUniversidad de Zaragoza
000129833 7102_ $$11006$$2413$$aUniversidad de Zaragoza$$bDpto. Fisiatría y Enfermería$$cÁrea Fisioterapia
000129833 773__ $$g11, 12 (2023), 3122 [12 pp.]$$tBiomedicines$$x2227-9059
000129833 8564_ $$s302027$$uhttps://zaguan.unizar.es/record/129833/files/texto_completo.pdf$$yVersión publicada
000129833 8564_ $$s2806521$$uhttps://zaguan.unizar.es/record/129833/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000129833 909CO $$ooai:zaguan.unizar.es:129833$$particulos$$pdriver
000129833 951__ $$a2024-11-22-12:05:14
000129833 980__ $$aARTICLE